comparemela.com

Latest Breaking News On - Pharma analyst - Page 1 : comparemela.com

Climate Change Fuels Surge in Multiple Sclerosis Cases

Climate change-induced exacerbations will increase the number of multiple sclerosis cases.

Sanofi aubagioJos opdenakkerPharma analystCompare newExisting standards globaldataPharma intelligence center

GlobalData : Innovent Biologics mazdutide can pave way for transformative T2D treatment, says GlobalData

24 May, 2024 Innovent Biologics mazdutide can pave way for transformative T2D treatment, says GlobalData Share Print page .

Eli lillyInnovent biologicsNelluri geethaInnovent biologics incGlobaldata pharmaceutical intelligence centerPharmaceutical intelligence centerPharma analyst

Diabetes and Obesity Market of GLP-1 Drugs Will Be $125 Billion By 2033!

GLP-1 drugs, the marvel drugs, in recent decades, have led the market significantly, with a market projection of $125 billion by 2033.

United kingdomOzempic wegovyCostanza alciatiLilly mounjaroNovo nordiskMarket forecastMarket analysisPharma analyst

Roche s therapy shows promise in slowing Parkinson s disease motor progression: GlobalData - Pharma News

Roche s therapy shows promise in slowing Parkinson s disease motor progression: GlobalData - Pharma News
financialexpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from financialexpress.com Daily Mail and Mail on Sunday newspapers.

United statesLorraine palmerParkinson progression marker initiativeAmerican academy of neurologyAmerican academyProgression marker initiativePharma analystColorectal cancer

GlobalData : Roche s PRX-002 shows promise in slowing Parkinson s disease motor progression, says GlobalData

19 Apr, 2024 Roche s PRX-002 shows promise in slowing Parkinson s disease motor progression, says GlobalData Share Print.

United statesLorraine palmerParkinson progression marker initiativeMovement disorder societyAmerican academy of neurologyAmerican academyPharma analystProgression marker initiativeMovement disorder society sponsored revisionUnified parkinsonDisease rating scale

vimarsana © 2020. All Rights Reserved.